Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-08-21

Clinical Trial Update: Study to Evaluate Safety and Efficacy of Peroneal Transcutaneous NeuroModulation in Subjects With Parkinson's Disease and Essential Tremor [NA]

View source ↗

Summary

Completed clinical trial evaluating safety and efficacy of peroneal transcutaneous neuro modulation in Parkinson's disease and essential tremor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Peroneal Transcutaneous NeuroModulation

Snippet

Sponsor: Stimvia s.r.o. | Conditions: Parkinson's Disease, Essential Tremor | NA | Status: COMPLETED